Stock info Basilea Pharmaceutica | Filter  Basic-Info

Stock: Basilea Pharmaceutica (Swiss large cap), ISIN: CH0011432447

Last Price 41.20 Max Price 47.10
Min Price 32.25 1 Year return -10.04
Avg. Target 0.00 Expected Return -
Sector Health Care Subsector Pharmaceuticals
Sell 0 Rating
Hold 0 Concensus
Buy 0
Annual report 2015

Loading...

Contact info:Country: SwitzerlandWebsite: www.basilea.com

Sector Review Basilea Pharmaceutica

Loading...
Year Turnover Total sector Market share
2019 134 615,670 0.02 %
2020 128 638,104 0.02 %
2021 148 727,997 0.02 %
2022 148 787,317 0.02 %
2023 0 0 0.00 %

Advice Basilea Pharmaceutica

No Records Found




News Basilea Pharmaceutica

No Records Found

Annual reports Basilea Pharmaceutica

2017 2018 2019 2020 2021

Profile Basilea Pharmaceutica

Basilea Pharmaceutica

(CH0011432447)

The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year gave good returns for Basilea Pharmaceutica investors

Over the last 12 months, that were loss-making period for the investors in Basilea Pharmaceutica, the stock lost around 22 percent. Over the period from December 2011 till December 2016 the stock rose on average 139 percent. Basilea Pharmaceutica's revenues between 2011 and 2015 were very constant and moved between 57,88 million CHFF and 51,65 million CHFF. The net results between 2011 and 2015 were very constant and fluctuated between -57,65 million CHFF and -61,6 million CHFF.

Basilea Pharmaceutica paid out dividends in the past 5 years. Basilea Pharmaceutica's dividend return over the period 2011 - 2015 was around 5 percent per year.

At the end of 2015 Basilea Pharmaceutica employed at around 23 people.

Basilea Pharmaceutica financed with a quite low debt position

As per the end of 2015 the Swiss company's balance sheet equaled 398,74 million CHFF. The total debt of the pharmaceutical company was at the end of 2015 383,88 million CHFF, which equals around 96,27 percent of the total balance sheet. Last year the pharmaceutical company's price/earnings-ratio (PE) was around -15. So the investors valued the stock at -15 times 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.

At the end of 2015 the Swiss company's market capitalization equaled around 958,64 million CHFF. At the end of 2015 the Swiss company had around 10,11 million stocks listed.

All the annual reports of Basilea Pharmaceutica are available here. More information about Basilea Pharmaceutica can be found it's website. .


Results Basilea Pharmaceutica

Results
2015
2016
2017
2018
2019
2020
Revenue
53
66
102
133
134
128
Costs
114
117
121
164
157
142
Profit
-62
-51
-19
-31
-22
-15
Margin of profit
-116.60
-77.74
-19.07
-23.65
-16.68
-11.53
ROI
-414.54
146.54
46.72
47.01
24.12
14.42

Balance Basilea Pharmaceutica

Balance
2015
2016
2017
2018
2019
2020
Equity
15
-35
-41
-67
-93
-102
Debt
384
363
393
348
314
332
Total assets
399
328
351
282
221
230
Solvency
3.73
-10.68
-11.80
-23.67
-41.97
-44.41
Cash
365
239
261
223
129
162
Cashflow
-68
-75
19
-79
-64
-54
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-0.18
-0.21
0.05
-0.23
-0.20
-0.16

Details Basilea Pharmaceutica

Details
2016
2017
2018
2019
2020
Price
96.30
73.10
75.90
39.96
46.86
Eps
-5.07
-1.79
-2.89
-2.08
-1.43
Price/earnings-ratio
-18.99
-40.84
-26.26
-19.21
-28.81
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
-3.24
-3.81
-6.21
-8.63
-9.39
Market to book
-0.03
-0.05
-0.08
-0.22
-0.23
Cashflow per stock
-6.94
1.75
-7.37
-5.93
-4.98
Stocks
11
11
11
11
11
Market Cap
1.041.19
794.72
815.52
430.53
447.73

Dividend Basilea Pharmaceutica


Price info Basilea Pharmaceutica

Date
Price
13 Nov 2024
41.20
08 Nov 2024
42.50
05 Nov 2024
43.65
31 Oct 2024
43.50
29 Oct 2024
44.55
23 Oct 2024
44.40
19 Oct 2024
45.60
16 Oct 2024
44.95
14 Oct 2024
45.65
05 Oct 2024
44.75
02 Oct 2024
45.60
27 Sep 2024
47.10
20 Sep 2024
45.80
17 Sep 2024
44.85
13 Sep 2024
45.40
28 Aug 2024
44.60
26 Aug 2024
44.70
23 Aug 2024
44.90
11 Aug 2024
38.20
07 Aug 2024
38.35
05 Aug 2024
37.45
01 Aug 2024
39.75
30 Jul 2024
39.40
26 Jul 2024
39.30
23 Jul 2024
40.20
16 Jul 2024
39.70
10 Jul 2024
39.70
09 Jul 2024
39.55
04 Jul 2024
38.55
02 Jul 2024
40.90